Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2013-04-01 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: IVRY-SUR-SEINE (94200), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BENDJEDDOU : revenue, balance sheet and financial ratios
PHARMACIE BENDJEDDOU is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in IVRY-SUR-SEINE (94200),
this company of category PME
shows in 2022 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BENDJEDDOU (SIREN 791653801)
Indicator
2024
2023
2022
2021
2020
2018
2017
Revenue
N/C
N/C
2 511 282 €
N/C
N/C
N/C
N/C
Net income
31 328 €
-107 769 €
101 276 €
105 527 €
63 639 €
102 685 €
61 997 €
EBITDA
N/C
N/C
195 531 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
4.0%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE BENDJEDDOU generates positive net income of 31 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 62 k€ -> 31 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
31 328 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 331%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
330.668%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
13.05%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2020
2021
2022
2023
2024
Debt ratio
480.005
290.421
347.866
381.929
313.852
694.92
330.668
Financial autonomy
12.144
17.742
17.358
15.252
16.695
7.942
13.05
Repayment capacity
None
None
None
None
2.877
None
None
Cash flow / Revenue
None%
None%
None%
None%
7.463%
None%
None%
Sector positioning
Debt ratio
330.672024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE BENDJEDDOU (330.67) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
13.05%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE BENDJEDDOU (13.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
2.88 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE BENDJEDDOU (2.88) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 122.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2020
2021
2022
2023
2024
Liquidity ratio
175.282
159.456
285.089
242.99
207.047
137.117
122.979
Interest coverage
None
None
None
None
2.09
None
None
Sector positioning
Liquidity ratio
122.982024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch-29 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE BENDJEDDOU (122.98) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
2.09x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE BENDJEDDOU (2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 35 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1098 days. Excellent situation: suppliers finance 1063 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
35 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1098 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BENDJEDDOU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
461 775 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
33
0
0
Customer payment term (days)
0
0
0
0
0
0
35
Supplier payment term (days)
0
0
0
0
42
0
1098
Positioning of PHARMACIE BENDJEDDOU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE BENDJEDDOU is estimated at
437 362 €
(range 304 572€ - 654 318€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
304k€437k€654k€
437 362 €Range: 304 572€ - 654 318€
NAF 5 année 2024
Valuation method used
Net Income Multiple
31 328 €
×
14.0x
=437 362 €
Range: 304 572€ - 654 319€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BENDJEDDOU with other companies in the same sector:
Frequently asked questions about PHARMACIE BENDJEDDOU
What is the revenue of PHARMACIE BENDJEDDOU ?
The revenue of PHARMACIE BENDJEDDOU in 2022 is 2.5 M€.
Is PHARMACIE BENDJEDDOU profitable?
Yes, PHARMACIE BENDJEDDOU generated a net profit of 31 k€ in 2024.
Where is the headquarters of PHARMACIE BENDJEDDOU ?
The headquarters of PHARMACIE BENDJEDDOU is located in IVRY-SUR-SEINE (94200), in the department Val-de-Marne.
Where to find the tax return of PHARMACIE BENDJEDDOU ?
The tax return of PHARMACIE BENDJEDDOU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BENDJEDDOU operate?
PHARMACIE BENDJEDDOU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart